![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » QLT INC. Q1 PROFIT DROPS TO $12.1 MILLION US FROM $15.3 MILLION AS REVENUES FALL
QLT INC. Q1 PROFIT DROPS TO $12.1 MILLION US FROM $15.3 MILLION AS REVENUES FALL
April 27, 2006
Eye drug developer QLT Inc. reported lower profits in the first quarter as sales dropped and legal expenses rose. The Vancouver company said Thursday it lost $12.1 million US or 13 cents a share for the three months ended March 31, down from profits of $15.6 million or 16 cents a share last year. QLT said its profit decline was primarily due to a reduction in sales of its Visudyne eye drug and higher legal expenses.
Canadian Business (http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=b042719A)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct